BRL-201

BRL-201 · Bioray Laboratories

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRL-201, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma [Phase 1]